Dr. Chien Wong MD

Practice: Great Ormond Street Hospital for Children (GOSH)

Location: London

Website: https://www.gosh.com.kw/

Phone:

Email: privateinfo@gosh.nhs.uk

Mr Chien Wong is a Vitreoretinal Surgeon who works in the Ophthalmology department. He is Head of the Retinopathy of Prematurity Retinal Detachment team at GOSH, which is the UK national centre for the complex condition. His area of expertise includes Paediatric Vitreoretinal Surgery and Endoscopic vitrectomy in babies and young children. In 2017, he was named in the annual Power List, a global top 50 list of rising stars in ophthalmology.

He is among a handful of ophthalmologists in the world with a super-specialty practice in complex paediatric vitreoretinal surgery and retinovascular diseases, in addition to his adult VR work. He is a world leading expert in endoscopic vitrectomy across a spectrum of adult and paediatric diseases. In 2014, he introduced novel endoscopic vitrectomy for retinopathy of prematurity (ROP) to the UK, making GOSH only one of only two centres in the world with expertise in this treatment. With Dr Wong as the Head of ROP Retinal Detachment Surgery, GOSH is now the national surgical centre for the United Kingdom.

He is clinical and research interests include vitreoretinal surgery in adults and children, paediatric retinovascular diseases, genomic medicine and surgical approaches for gene therapy, and vitreoretinal surgical devices development. Dr. Wong is the UK Chief Investigator and Moorfields Eye Hospital Principal Investigator for the RAINBOW trial, an international randomised controlled trial of intravitreal ranibizimab versus standard-of-care retinal laser, as well as being a co-investigator in 3 phase I/II retinal gene therapy trials at Moorfields Eye Hospital. He has over 30 publications, has written numerous book chapters, is the editor of two forthcoming books, has won over 15 prizes over his career and has run over 20 surgical courses as lead or co-instructor both in the UK and internationally. This includes being the current course directors at the American Academy of Ophthalmology annual meeting of Advances in Intraocular Endoscopic Surgery: Anterior and Posterior Segment Techniques since 2012, Paediatric Vitreoretinal Disorders: Current & Future Management.

  • Fellowship, Vitreoretinal surgery, Moorfields Eye Hospital

    Further 3 years paediatric vitreoretinal surgical training in the USA at (i) William Beaumont Hospital, Michigan (Professors Trese, Capone & Drenser) and (ii) Children’s Hospital Los Angeles (Prof. Thomas Lee)

    Darzi Clinical Leadership Fellow, Moorfields Eye Hospital. Inaugural group of cross-specialty fellows in the UK. Spearheaded development of innovative leadership programme at Moorfields with multiple awards.

    MB BS

    Royal College of Surgeons - FRCSEd(Ophth)

    Royal College of Ophthalmologists UK - MRCOphth

    UK General Medical Council (GMC) number 4635118

    USA ECFMG USMLE certification

  • British and Eire Association of Vitreoretinal Surgeons (BEAVRS)

    European Retina society (EURETINA)

    American Society of Retina Specialists (ASRS)

    American Academy of Ophthalmology (AAO)

    Association of Pediatric Retinal Surgeons

    Working with the California-based NGO the Armenian Eye Care Project (www.aecp.com), supported by the Armenian Health Ministry and funded by the US Agency for International Development (USAID)

    Mr. Wong is on several scientific advisory boards of vitreoretinal surgical companies (by invitation)

  • Areas of Expertise:

    • Paediatric vitreoretinal surgery

    • Endoscopic vitrectomy in babies and young children

    • Paediatric retinovascular diseases

    • Adult vitreoretinal surgery

    • Vitreoretinal devices development

    Research Interests:

    Mr. Wong is interested in ways to improve the outcomes of paediatric vitreoretinal surgery and collaborates with leading international specialists in the field. His interests include

    • UK Chief Investigator and Moorfields Eye Hospital Principal Investigator for the RAINBOW trial, an international randomised controlled trial comparing anti-VEGF (Lucentis) and laser treatment in ROP.

    • Co-investigator and retinal surgeon in three phase I/II gene therapy trial.

    • Surgical innovation in paediatric vitreoretinal surgery, including ROP and FEVR

    • Endoscopic vitrectomy for complex retinal detachment in infants and young children, including ROP, FEVR, trauma and post-retinoblastoma treated eyes.

    • Surgery for ROP. International collaboration to examine the role of bilateral simultaneous vitreoretinal surgery in babies with retinal detachment in ROP

    • FEVR surgical outcomes

    • Retinovascular diseases

    • OCT angiography imaging in Coats’ disease, FEVR and Incontinentia pigmenti.

    Mr Wong has received over 20 prizes and awards (national and international) over his career, including from the Special Trustees of Moorfields Eye Hospital (2011, 2012), EURETINA (2011), American Academy of Ophthalmology (2007, 2013, 2017) and American Society of Retina Specialists (2011, 2012).

    In 2017, he was named in the annual Power List, a global top 50 list of rising stars in ophthalmology.

FAQ

At the Jack McGovern Coats’ Disease Foundation, we are often contacted by anxious parents or patients who are seeking information after receiving a diagnosis of Coats’ Disease. The questions below are provided as a resource to assist you as you and your doctor decide the best approach for treatment. These questions do not constitute any form of medical advice or diagnosis. Each patient is unique. An experienced retinal specialist who has examined the patient is the best source of information for diagnosis and treatment. We always recommend getting a second opinion.

Questions to Ask Your Doctor (Download PDF)

  • Ahead of any treatments or procedures, it is important to ask yourself and the doctor the following questions:

    • How do you know that this is Coats’ Disease?

    • Has your doctor treated other patients with Coats’ Disease?

    • Have you sought a second opinion? If not, please consult our Doctor Directory for knowledgeable doctors in your area.

    • What Stage of Coats’ Disease is he/she in?

    • Will his/her vision get worse over time?

    • Will the eye have pain?

    • Will his/her eye start to turn out? Is muscle corrective surgery an option?

    • Are cataracts likely?

    • How likely is glaucoma? (due to retinal detachment)

    • Is there calcification?

    • What is the anticipated disease progression?

    • Is there a thorough vision exam available?

    • Where is the vision affected? (central/peripheral/distance)

    • Does he/she have depth perception? (3D visibility)

    • What about the non-Coats’ eye?

    • To what extent is his/her vision affected?

    • Will we be able to use this as a baseline to measure progress/decline?

Find a Doctor

Are you a Doctor?

Contact us to learn more about taking the White Coats to Cure Coats pledge today.